-
1دورية أكاديمية
المؤلفون: Wenxin Huang (336899), Jia-Xi Wang (624478), Xiaofei Shen (561186), Yuqin Lei (8693364), Xueqin Chen (713992), Da Jia (8551359), Xia Zhang (41398), Qingxiang Sun (241307)
مصطلحات موضوعية: Biochemistry, Medicine, Genetics, Pharmacology, Biotechnology, Developmental Biology, Hematology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, valuable lead compound, structural analysis revealed, covalent inhibitor kpt, develop drug leads, new crm1 inhibitor, noncovalent crm1 inhibitor, new targets, drug repurposing, drug doxorubicin, crm1 inhibitors, works laid, worked synergistically, virtually screened, various cancers, taken together, solid foundation, noncovalent ones, marketed drugs
-
2دورية أكاديمية
المؤلفون: Vanesa Nozal (9034427), Loreto Martínez-González (2911010), Marta Gomez-Almeria (11896116), Claudia Gonzalo-Consuegra (11896119), Paula Santana (3820921), Apirat Chaikuad (244322), Eva Pérez-Cuevas (11896122), Stefan Knapp (244328), Daniel Lietha (193525), David Ramírez (4053370), Sabrina Petralla (5681105), Barbara Monti (1504795), Carmen Gil (146118), Angeles Martín-Requero (11896125), Valle Palomo (356637), Eva de Lago (4767084), Ana Martinez (1313100)
مصطلحات موضوعية: Biophysics, Biochemistry, Cell Biology, Neuroscience, Pharmacology, Immunology, Hematology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, promising therapeutic strategy, motor neuron preservation, future als therapy, valuable lead compound, ttbk1 inhibitors emerge, 29 b, valuable inhibitors, vivo <, tubulin kinase, translational modifications, spinal cord, proposing pyrrolopyrimidine, pathological hallmark, new avenue, m2 anti, inflammatory microglia, familiar patients, effective treatment, cell cultures, biological evaluation, animal models
-
3
المؤلفون: Wenxin Huang (336899), Jia-Xi Wang (624478), Xiaofei Shen (561186), Yuqin Lei (8693364), Xueqin Chen (713992), Da Jia (8551359), Xia Zhang (41398), Qingxiang Sun (241307)
مصطلحات موضوعية: Biochemistry, Medicine, Genetics, Pharmacology, Biotechnology, Developmental Biology, Hematology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, valuable lead compound, structural analysis revealed, covalent inhibitor kpt, develop drug leads, new crm1 inhibitor, noncovalent crm1 inhibitor, new targets, drug repurposing, drug doxorubicin, crm1 inhibitors, works laid, worked synergistically, virtually screened, various cancers, taken together, solid foundation, noncovalent ones, marketed drugs
-
4
المؤلفون: Wenxin Huang (336899), Jia-Xi Wang (624478), Xiaofei Shen (561186), Yuqin Lei (8693364), Xueqin Chen (713992), Da Jia (8551359), Xia Zhang (41398), Qingxiang Sun (241307)
مصطلحات موضوعية: Biochemistry, Medicine, Genetics, Pharmacology, Biotechnology, Developmental Biology, Hematology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, valuable lead compound, structural analysis revealed, covalent inhibitor kpt, develop drug leads, new crm1 inhibitor, noncovalent crm1 inhibitor, new targets, drug repurposing, drug doxorubicin, crm1 inhibitors, works laid, worked synergistically, virtually screened, various cancers, taken together, solid foundation, noncovalent ones, marketed drugs
-
5
المؤلفون: Wenxin Huang (336899), Jia-Xi Wang (624478), Xiaofei Shen (561186), Yuqin Lei (8693364), Xueqin Chen (713992), Da Jia (8551359), Xia Zhang (41398), Qingxiang Sun (241307)
مصطلحات موضوعية: Biochemistry, Medicine, Genetics, Pharmacology, Biotechnology, Developmental Biology, Hematology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, valuable lead compound, structural analysis revealed, covalent inhibitor kpt, develop drug leads, new crm1 inhibitor, noncovalent crm1 inhibitor, new targets, drug repurposing, drug doxorubicin, crm1 inhibitors, works laid, worked synergistically, virtually screened, various cancers, taken together, solid foundation, noncovalent ones, marketed drugs
-
6
المؤلفون: Wenxin Huang (336899), Jia-Xi Wang (624478), Xiaofei Shen (561186), Yuqin Lei (8693364), Xueqin Chen (713992), Da Jia (8551359), Xia Zhang (41398), Qingxiang Sun (241307)
مصطلحات موضوعية: Biochemistry, Medicine, Genetics, Pharmacology, Biotechnology, Developmental Biology, Hematology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, valuable lead compound, structural analysis revealed, covalent inhibitor kpt, develop drug leads, new crm1 inhibitor, noncovalent crm1 inhibitor, new targets, drug repurposing, drug doxorubicin, crm1 inhibitors, works laid, worked synergistically, virtually screened, various cancers, taken together, solid foundation, noncovalent ones, marketed drugs
-
7
المؤلفون: Wenxin Huang (336899), Jia-Xi Wang (624478), Xiaofei Shen (561186), Yuqin Lei (8693364), Xueqin Chen (713992), Da Jia (8551359), Xia Zhang (41398), Qingxiang Sun (241307)
مصطلحات موضوعية: Biochemistry, Medicine, Genetics, Pharmacology, Biotechnology, Developmental Biology, Hematology, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, valuable lead compound, structural analysis revealed, covalent inhibitor kpt, develop drug leads, new crm1 inhibitor, noncovalent crm1 inhibitor, new targets, drug repurposing, drug doxorubicin, crm1 inhibitors, works laid, worked synergistically, virtually screened, various cancers, taken together, solid foundation, noncovalent ones, marketed drugs
-
8
المؤلفون: Vanesa Nozal (9034427), Loreto Martínez-González (2911010), Marta Gomez-Almeria (11896116), Claudia Gonzalo-Consuegra (11896119), Paula Santana (3820921), Apirat Chaikuad (244322), Eva Pérez-Cuevas (11896122), Stefan Knapp (244328), Daniel Lietha (193525), David Ramírez (4053370), Sabrina Petralla (5681105), Barbara Monti (1504795), Carmen Gil (146118), Angeles Martín-Requero (11896125), Valle Palomo (356637), Eva de Lago (4767084), Ana Martinez (1313100)
مصطلحات موضوعية: Biophysics, Biochemistry, Cell Biology, Neuroscience, Pharmacology, Immunology, Hematology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, promising therapeutic strategy, motor neuron preservation, future als therapy, valuable lead compound, ttbk1 inhibitors emerge, 29 b, valuable inhibitors, vivo <, tubulin kinase, translational modifications, spinal cord, proposing pyrrolopyrimidine, pathological hallmark, new avenue, m2 anti, inflammatory microglia, familiar patients, effective treatment, cell cultures, biological evaluation, animal models